Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
Launched by M.D. ANDERSON CANCER CENTER · Feb 26, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different lifestyle factors—like mental health, social support, diet, and exercise—affect the quality of life and health outcomes for patients with melanoma, a type of skin cancer. By understanding these connections, researchers hope to create new ways to help improve the lives of people facing melanoma and guide doctors in advising their patients about healthy living.
To participate in this study, you need to be diagnosed with melanoma or related skin conditions and should be comfortable reading and understanding English. The trial is open to both men and women aged 65 to 74. If you decide to join, you will be asked to complete a survey, either online or on paper, about your lifestyle and well-being. This is a chance to contribute to important research that may lead to better support and treatment for melanoma patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of melanoma, precursor lesions, and associated cutaneous pathology
- • Able to read and understand English
- • Willing to complete an online or paper survey
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Jennifer L McQuade
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials